Search results
AstraZeneca withdraws Covid vaccine worldwide after admitting it can cause rare blood clots
The Independent via Yahoo News· 2 days agoAstraZeneca is withdrawing its Covid-19 vaccine worldwide, months after the pharma giant admitted...
AstraZeneca Pulls Out Its COVID-19 Vaccine From Global Markets After Court Docs Shows Side Effects -...
EconoTimes· 2 days agoAstraZeneca plc, a British-Swedish pharmaceutical and biotechnology company, is reportedly...
AstraZeneca pulls its COVID-19 vaccine from Europe
Boston Herald· 13 hours agoThe pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines ...
...Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine and Develop...
FOX 4 Kansas City· 4 hours ago-M™ adjuvant, has entered into a co-exclusive licensing agreement with Sanofi (Nasdaq: SNY). The terms of the agreement include: a co-exclusive license to co-commercialize Novavax's current ...
AstraZeneca withdraws Covid-19 vaccine, citing low demand | CNN Business
CNN.com· 2 days agoThe vaccine — called Vaxzevria and developed in partnership with the University of Oxford — has been...
Novavax shares surge on new $1.4 billion deal with Sanofi
Market Watch· 57 minutes agoNovavax on Friday said it had struck a $1.4 billion deal with Sanofi to commercialize its existing ...
Was COVID vaccine recalled over health danger fears? What we know
Newsweek· 22 hours agoPharmaceutical company AstraZeneca has initiated a global withdrawal of its COVID-19 vaccine just...
Four ways the vaccine rush will define infectious disease trends for CROs in 2024
Pharmaceutical Technology via Yahoo Finance· 55 minutes agoThe speed and flexibility required in clinical trials for COVID-19 set a new precedent for what can...
Novavax signs COVID-19 license deal with Sanofi, removes doubt about business viability
Reuters via Yahoo News· 4 hours agoPARIS (Reuters) -Novavax on Friday erased doubts about its ability to remain in business and struck...
Novavax Reports First Quarter 2024 Financial Results and Operational Highlights
WKRN Nashville· 4 hours agoAnnounces co-exclusive licensing agreement with Sanofi to co-commercialize COVID-19 vaccine, develop novel COVID-& ...